Skip to main content
SpringerLink
Log in

Painful Medical Diseases

  • Chapter
  • First Online:
Pain Management for Clinicians

  • 1411 Accesses

Abstract

Chronic pain related to painful medical diseases is an extensive field that requires more awareness and large clinical research trials into optimal treatments that can increase patient satisfaction and quality of life. Using a multidisciplinary approach requires an array of medications, in addition to behavioral/psychological, interventional, and physical therapy treatments. Multimodal therapy through various medications described in this chapter is also essential to creating a balanced treatment plan that reduces risk and side effects from any single agent, especially opioids. The opioid epidemic is no doubt prevalent at this time, and recent guidelines reinforce the need for improved patient and physician education and access to safer and more effective options. When opioids are essential for certain medical conditions, increased awareness of long-term side effects and associated comorbidities can optimize the balance between risks and benefits.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. https://azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/prescribing-guidelines/az-opioid-prescribing-guidelines.pdf.

  2. https://www.hhs.gov/ash/advisory-committees/pain/reports/2018-12-draft-report-on-updates-gaps-inconsistencies-recommendations/index.html.

  3. Baichoo P, Asuncion A, El-Chaar G. Intravenous acetaminophen for the Management of Pain during vaso-occlusive crises in pediatric patients. Pharm Therap. 2019;44(1):5.

    Google Scholar 

  4. Perlin E, Finke H, Castro O, Rana S, Pittman J, Burt R, Ruff C, McHugh D. Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis. Am J Hematol. 1994;46(1):43–7.

    Article  CAS  PubMed  Google Scholar 

  5. Eke FU, Obamyonyi A, Eke NN, Oyewo EA. An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis. Tropical Med Int Health. 2000;5(2):81–4.

    Article  CAS  Google Scholar 

  6. Hardwick JW, Givens TG, Monroe KW, King WD, Lawley DE. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Pediatr Emerg Care. 1999;15(3):179–82.

    Article  PubMed  Google Scholar 

  7. Wright SW, Norris RL, Mitchell TR. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect. Ann Emerg Med. 1992;21(8):925–8.

    Article  CAS  PubMed  Google Scholar 

  8. Bartolucci P, El Murr T, Roudot-Thoraval F, Habibi A, Santin A, Renaud B, Noël V, Michel M, Bachir D, Galactéros F, Godeau B. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood. 2009;114(18):3742–7.

    Article  CAS  PubMed  Google Scholar 

  9. Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol. 2003;120(5):744–52.

    Article  PubMed  Google Scholar 

  10. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E. A phase 3 trial of l-glutamine in sickle cell disease. N Engl J Med. 2018;379(3):226–35.

    Article  CAS  PubMed  Google Scholar 

  11. Ezenwa MO, Yao Y, Engeland CG, Molokie RE, Wang ZJ, Suarez ML, Wilkie DJ. A randomized controlled pilot study feasibility of a tablet-based guided audio-visual relaxation intervention for reducing stress and pain in adults with sickle cell disease. J Adv Nurs. 2016;72(6):1452–63.

    Article  PubMed  Google Scholar 

  12. Thomas VJ. Cognitive behavioural therapy in pain management for sickle cell disease. Int J Palliat Nurs. 2000;6(9):434–42.

    Article  CAS  PubMed  Google Scholar 

  13. Moody K, Abrahams B, Baker R, Santizo R, Manwani D, Carullo V, Eugenio D, Carroll A. A randomized trial of yoga for children hospitalized with sickle cell vaso-occlusive crisis. J Pain Symptom Manag. 2017;53(6):1026–34.

    Article  Google Scholar 

  14. Rodgers-Melnick SN, Matthie N, Jenerette C, Griest Pell TJ, Lane D, Fu P, Margevicius S, Little JA. The effects of a single electronic music improvisation session on the pain of adults with sickle cell disease: a mixed methods pilot study. J Music Ther. 2018;55(2):156–85.

    Article  PubMed  Google Scholar 

  15. Schlaeger JM, Molokie RE, Yao Y, Suarez ML, Golembiewski J, Wilkie DJ, Votta-Velis G. Management of sickle cell pain using pregabalin: a pilot study. Pain Manag Nurs. 2017;18(6):391–400.

    Article  PubMed  Google Scholar 

  16. Robie IC, Kellner JD, Coppes MJ, Shaw D, Brown E, Good C, O’brodovich H, Manson D, Olivieri NF, Zipursky AA, Koren G. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatr Hematol Oncol. 1992;9(4):317–26.

    Article  Google Scholar 

  17. https://www.hemophilia.org/Researchers-Healthcare-Providers/Medical-and-Scientific-Advisory-Council-MASAC/MASAC-Recommendations/Guidelines-for-Emergency-Department-Management-of-Individuals-with-Hemophilia-and-Other-Bleeding-Disorders.

  18. Elander J, Barry T. Analgesic use and pain coping among patients with haemophilia. Haemophilia. 2003;9(2):202–13.

    Article  CAS  PubMed  Google Scholar 

  19. Buzzard BM. Physiotherapy for prevention and treatment of chronic hemophilic synovitis. Clin Orthop Relat Res. 1997;343:42–6.

    Article  Google Scholar 

  20. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood. 2009;114(26):5256–63.

    Article  CAS  PubMed  Google Scholar 

  21. Riley RR, Witkop M, Hellman E, Akins S. Assessment and management of pain in haemophilia patients. Haemophilia. 2011;17(6):839–45.

    Article  CAS  PubMed  Google Scholar 

  22. Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilicsynovitis, target joints, and pain in adults and children with haemophilia. Haemophilia. 2006;12(5):514–7.

    Article  CAS  PubMed  Google Scholar 

  23. Cheng Y, Hitchcock SA. Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs. 2007;16(7):951–65.

    Article  CAS  PubMed  Google Scholar 

  24. Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin. 2007;23(1):17–24.

    Article  CAS  PubMed  Google Scholar 

  25. Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. J Neurol. 2013;260(4):984–97.

    Article  CAS  PubMed  Google Scholar 

  26. Turcotte D, Doupe M, Torabi M, Gomori A, Ethans K, Esfahani F, Galloway K, Namaka M. Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial. Pain Med. 2015;16(1):149–59.

    Article  PubMed  Google Scholar 

  27. Vollmer TL, Robinson MJ, Risser RC, Malcolm SK. A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis. Pain Pract. 2014;14(8):732–44.

    Article  PubMed  Google Scholar 

  28. Chitsaz A, Janghorbani M, Shaygannejad V, Ashtari F, Heshmatipour M, Freeman J. Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. Clin J Pain. 2009;25(4):281–5.

    Article  PubMed  Google Scholar 

  29. Rossi S, Mataluni G, Codeca C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. Eur J Neurol. 2009;16(3):360–6.

    Article  CAS  PubMed  Google Scholar 

  30. Knopp-Sihota JA, Newburn-Cook CV, Homik J, Cummings GG, Voaklander D. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporos Int. 2012;23(1):17–38.

    Article  CAS  PubMed  Google Scholar 

  31. Dionyssiotis Y. Management of osteoporotic vertebral fractures. Int J Gen Med. 2010;3:167.

    Article  PubMed  PubMed Central  Google Scholar 

  32. McGirt MJ, Parker SL, Wolinsky JP, Witham TF, Bydon A, Gokaslan ZL. Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced-based review of the literature. Spine J. 2009;9(6):501–8.

    Article  PubMed  Google Scholar 

  33. Lal H, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96.

    Article  PubMed  Google Scholar 

  34. Tyring S, et al. Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study. Br J Ophthalmol. 2001;85:576–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Whitley R, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med. 1996;125:376–83.

    Article  CAS  PubMed  Google Scholar 

  36. Cui J, et al. Effect of repetitive intracutaneous injections with local anesthetics and steroids for acute thoracic herpes zoster and incidence of postherpetic neuralgia. Pain Med. 2017;18:1566–72.

    PubMed  Google Scholar 

  37. Wijck AV, et al. The PINE study of epidural steroids and local anesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 2006;367:219–24.

    Article  PubMed  CAS  Google Scholar 

  38. Fujiwara A, et al. Transforaminal vs interlaminal epidural steroid injection for acute-phase shingles: a randomized, prospective trial. Pain Physician. 2018;21:373–82.

    Article  PubMed  Google Scholar 

  39. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manag. 1997;13(6):327–31.

    Article  CAS  Google Scholar 

  40. Graff-Radford S, Shaw L, Naliboff B. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000;16(3):188–92.

    Article  CAS  PubMed  Google Scholar 

  41. Finnerup N, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Paice J, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(27):3325–45.

    Article  PubMed  Google Scholar 

  43. McNicol E, et al. NSAIDs or paracetamol, alone or combined with opioids, for cancer pain (Review). Cochrane Database Syst Rev. 2005;2

    Google Scholar 

  44. Karanikolas M, et al. Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency. Anesthesiology. 2011;114(5):1144–54.

    Article  CAS  PubMed  Google Scholar 

  45. Yousef A, Aborahma A. The preventive value of epidural calcitonin in patients with lower limb amputation. Pain Med. 2017;18:1745–51.

    PubMed  Google Scholar 

  46. Malavera A, et al. Repetitive transcranial magnetic stimulation for phantom limb pain in land mine victims: a double-blinded, randomized sham-controlled trial. J Pain. 2016;17(8):911–8.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Brunelli S, et al. Efficacy of progressive muscle relaxation, mental imagery, and phantom exercise training on phantom limb: a randomized controlled trial. Arch Phys Med Rehabil. 2015;96:181–7.

    Article  PubMed  Google Scholar 

  48. Abraham RB, Marouani N, Winbroum A. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol. 2002;10(3):268–74.

    Article  Google Scholar 

  49. Wilder-Smith C, Hill L, Laurent S. Post amputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology. 2005;103:619–28.

    Article  CAS  PubMed  Google Scholar 

  50. Bone M, Critchley P, Buggy D. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002;27(5):481–6.

    CAS  PubMed  Google Scholar 

  51. Wu C, et al. Morphine versus mexiletine for treatment of postamputation pain. Anesthesiology. 2008;109(2):289–96.

    Article  CAS  PubMed  Google Scholar 

  52. Eichenberger U, et al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg. 2008;106(4):1265–73.

    Article  CAS  PubMed  Google Scholar 

  53. Chan B, et al. Mirror therapy for phantom limb pain. N Engl J Med. 2007;357(21):2206–7.

    Article  CAS  PubMed  Google Scholar 

  54. Subedi B, Grossberg G. Phantom limb pain: mechanisms and treatment approaches. Pain Res Treat. 2011;2011:1–8.

    Article  Google Scholar 

  55. Gartner R, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.

    Article  PubMed  Google Scholar 

  56. Weinstein E, et al. Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. Cochrane Database Syst Rev. 2018;6

    Google Scholar 

  57. Amr Y, Yousef A. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26:381–5.

    Article  PubMed  Google Scholar 

  58. Mishra A, et al. Pregabalin in chronic post-thoracotomy pain. J Clin Diagn Res. 2013;7(8):1659–61.

    PubMed  PubMed Central  Google Scholar 

  59. Smith E, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Rao R, et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial. Cancer. 2007;110(9):2110–8.

    Article  CAS  PubMed  Google Scholar 

  61. Hershman D, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32(18):1941–67.

    Article  CAS  PubMed  Google Scholar 

  62. Prinsloo S, et al. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: a pilot study. Cancer. 2017;123:1989–97.

    Article  CAS  PubMed  Google Scholar 

  63. Delanian S, et al. Significant clinical improvement in radiation-induced lumbosacral polyradiculopathy by a treatment combining pentoxifylline, tocopherol, and clodronate (Pentoclo). J Neurol Sci. 2008;275:164–6.

    Article  CAS  PubMed  Google Scholar 

  64. Kataoka T, et al. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer. Auris Nasus Larynx. 2016;43:677–84.

    Article  PubMed  Google Scholar 

  65. Farooq O, et al. Novel treatment for radiation optic neuropathy with intravenous bevacizumab. J Neuroophthalmol. 2012;32:321–4.

    Article  PubMed  Google Scholar 

  66. Jacobs J, Grayson M. Trial of an anti-inflammatory agent (indomethacin) in low back pain with and without radicular involvement. Br Med J. 1968;3:158–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Ko S, et al. The effectiveness of oral corticosteroids for management of lumbar radiating pain: randomized, controlled trial study. Clin Orthop Surg. 2016;8:262–7.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Goldberg H, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA. 2015;313(19):1915–23.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Doheny K. Steroids no better for sciatica pain than placebo, study finds. HealthDay 2015 [cited 2019 Apr 30]; Available from: https://consumer.healthday.coom/bone-and-joint-information-4/pain-health-news-520/steroids-no-better-for-sciatica-pain-than-placebo-study-finds.

  70. Khoromi S, et al. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 2007;130:66–75.

    Article  CAS  PubMed  Google Scholar 

  71. Shahverdi E, et al. Evaluation of the efficacy and safety of gabapentin in treatment of lumbar radiculopathy: a randomized clinical trial. IOSR J Pharm. 2016;6(6):1–3.

    Article  CAS  Google Scholar 

  72. Finnerup N, Sindrup S, Jensen T. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–81.

    Article  PubMed  Google Scholar 

  73. Cruccu G, Truini A. A review of neuropathic pain: from guidelines to clinical practice. Pain Ther. 2017;6:S35–42.

    Article  Google Scholar 

  74. Sindrup S, Jensen T. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–7.

    Article  PubMed  Google Scholar 

  75. Sharav Y, et al. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987;31:199–209.

    Article  CAS  PubMed  Google Scholar 

  76. Richette P, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2016;76:29–42.

    Article  PubMed  Google Scholar 

  77. Billy C, et al. Corticosteroid or nonsteroidal antiinflammatory drugs for the treatment of acute gout: a systematic review of randomized controlled trials. J Rheumatol. 2018;45:128–36.

    Article  CAS  PubMed  Google Scholar 

  78. McMahan Z, Wigley F. Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management. Int J Clin Rheumatol. 2010;5(3):355–70.

    Article  Google Scholar 

  79. Ng W, et al. Phosphodiesterase inhibitors in vascular ischemia: a case report and review of their use in ischemic conditions. Can J Plast Surg. 2010;18:e5–9.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Stone P, Muller J. Nifedipine therapy for recurrent ischemic pain following myocardial infarction. Clin Cardiol. 1982;5:223–30.

    Article  CAS  PubMed  Google Scholar 

  81. Jimenez E, Whitney-Caglia L. Treatment of chronic lower extremity wound pain with nitroglycerin ointment. J Wound Ostomy Continence Nurs. 2012;39:649–52.

    Article  PubMed  Google Scholar 

  82. Silva Le, et al. Safety and efficacy of intravenous lidocaine for pain management in the emergency department: a systematic review. Ann Emerg Med. 2018;72:135–44.

    Article  Google Scholar 

  83. Vahidi E, et al. Comparison of intravenous lidocaine versus morphine in alleviating pain in patients with critical limb ischaemia. Emerg Med J. 2014;32:516–9.

    Article  PubMed  Google Scholar 

  84. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;6:CD007402.

    Google Scholar 

  85. Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults-an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;9:CD008659.

    Google Scholar 

  86. Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. https://painhealth.csse.uwa.edu.au/wp-content/uploads/2016/04/painHEALTH-NNT-and-NNH-for-pain-medications.pdf

  88. Citrome L, Weiss–Citrome A. A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Postgrad Med. 2012;124(1):83–93.

    Article  PubMed  Google Scholar 

  89. Leijon G, Boivie J. Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36(1):27–36.

    Article  CAS  PubMed  Google Scholar 

  90. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330(20):1411–7.

    Article  PubMed  Google Scholar 

  91. Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018;319(9):872–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Callinan CE, Neuman MD, Lacy KE, Gabison C, Ashburn MA. The initiation of chronic opioids: a survey of chronic pain patients. J Pain. 2017;18(4):360–5.

    Article  PubMed  Google Scholar 

  93. Harbaugh CM, Lee JS, Chua KP, et al. Association between long-term opioid use in family members and persistent opioid use after surgery among adolescents and young adults. JAMA Surg. 2019:e185838.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Trivedi MH. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 1):12–6.

    PubMed  PubMed Central  Google Scholar 

  95. Vladimir M, Bernadette D. Chronic pain and depression: understanding 2 culprits in common. Curr Psychiatr Ther. 2016;15(2):40–52.

    Google Scholar 

  96. Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.

    Article  Google Scholar 

  97. Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2017;30(4):407–17.

    Article  PubMed  Google Scholar 

  98. Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88(12):1547–60.

    Article  PubMed  Google Scholar 

  99. White JM. Pleasure into pain: the consequences of long-term opioid use. Addicti Behav. 2004;29(7):1311–24.

    Article  Google Scholar 

  100. Hah JM, Mackey S, Barelka PL, et al. Self-loathing aspects of depression reduce postoperative opioid cessation rate. Pain Med. 2014;15(6):954–64.

    Article  PubMed  Google Scholar 

  101. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomized trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347(8995):143–7.

    Article  CAS  PubMed  Google Scholar 

  102. Nedeljkovic SS, Wasan A, Jamison RN. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain. 2002;18(4 Suppl):S39–51.

    Article  PubMed  Google Scholar 

  103. Roy-byrne P, Sullivan MD, Sherbourne CD, et al. Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety. Clin J Pain. 2013;29(9):800–6.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Mazereeuw G, Sullivan MD, Juurlink DN. Depression in chronic pain: might opioids be responsible? Pain. 2018;159(11):2142–5.

    Article  PubMed  Google Scholar 

  105. Scherrer JF, Salas J, Copeland LA, et al. Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Fam Med. 2016;14(1):54–62.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Sullivan MD. Depression effects on long-term prescription opioid use, abuse, and addiction. Clin J Pain. 2018;34(9):878–84.

    PubMed  Google Scholar 

  107. Quinn PD, Hur K, Chang Z, et al. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017;158(1):140–8.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Deyo RA, Hallvik SE, Hildebran C, et al. Association between initial opioid prescribing patterns and subsequent long-term use among Opioid-Naïve patients: a statewide retrospective cohort study. J Gen Intern Med. 2017;32(1):21–7.

    Article  PubMed  Google Scholar 

  109. Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med. 2018;378(17):1567–9.

    Article  PubMed  Google Scholar 

  110. Braden JB, Edlund MJ, Sullivan MD. Suicide deaths with opioid poisoning in the United States: 1999-2014. Am J Public Health. 2017;107(3):421–6.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Bohnert ASB, Ilgen MA. Understanding links among opioid use, overdose, and suicide. N Engl J Med. 2019;380(14):1380.

    Article  PubMed  Google Scholar 

  112. Campbell G, Bruno R, Darke S, Shand F, Hall W, Farrell M, Degenhardt L. Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain. Clin J Pain. 2016;32(4):292–301.

    Article  PubMed  Google Scholar 

  113. Ilgen MA, Bohnert AS, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016;157(5):1079–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Bose J, Hedden SL, Lipari RN, Park-Lee E; Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health. https://www.samhsa.gov/data/report/2017-nsduh-annual-national-report.

  115. Ashburn MA, Fleisher LA. Increasing evidence for the limited role of opioids to treat chronic noncancer pain. JAMA. 2018;320(23):2427–8.

    Article  PubMed  Google Scholar 

  116. Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–64.

    PubMed  PubMed Central  Google Scholar 

  117. https://www.cdc.gov/drugoverdose/images/epidemic/3WavesOfTheRiseInOpioidOverdoseDeaths.png

  118. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat. 2014;71(7):821–6.

    Article  Google Scholar 

  119. Fulton-Kehoe D, Garg RK, Turner JA, Bauer AM, Sullivan MD, Wickizer TM, Franklin GM. Opioid poisonings and opioid adverse effects in workers in Washington State. Am J Ind Med. 2013;56(12):1452–62.

    Article  CAS  PubMed  Google Scholar 

  120. Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–21.

    Article  CAS  PubMed  Google Scholar 

  121. Cauley C, et al. Predictors of in-hospital postoperative opioid overdose after major elective operations: a nationally representative cohort study. Ann Surg. 2017;265(4):702–8.

    Article  PubMed  Google Scholar 

  122. Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study. Ann Intern Med. 2016;164(1):1–9.

    Article  PubMed  Google Scholar 

  123. Frank J, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Pain Management, UT Southwestern Medical Center, Dallas, TX, USA

    Robert S. Ackerman, Frederick Li, Tom Mario Davis & Nathaniel Loo

Authors
  1. Robert S. Ackerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederick Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tom Mario Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nathaniel Loo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nathaniel Loo .

Editor information

Editors and Affiliations

  1. Professor in the Department of Pain Management and Anesthesiology, UT Southwestern Medical Center, Eugene McDermott Center for Pain Management, Dallas, TX, USA

    Carl Edward Noe

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ackerman, R.S., Li, F., Davis, T.M., Loo, N. (2020). Painful Medical Diseases. In: Noe, C. (eds) Pain Management for Clinicians. Springer, Cham. https://doi.org/10.1007/978-3-030-39982-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-39982-5_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-39981-8

  • Online ISBN: 978-3-030-39982-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation